Pharmaceutical Sciences researchers have identified a new therapeutic target for the treatment of gout, a common type of arthritis that causes episodes of painful and stiff joints. The research lays the foundation for the development of potential new treatment strategies that could significantly improve the quality of life of millions of people around the world who suffer from the condition.
Darrell Jackson wants to train a new generation of healthcare practitioners in the Inland Northwest to help people with ALS and other neurodegenerative diseases live longer, healthier and happier lives.
An experienced educator who is nationally recognized for his work investigating the sometimes fatal after effects of strokes, Jackson is returning to WSU after spending nearly two decades away.
Pharmaceutical scientist Zhenjia Wang has developed a new technology that harnesses the immune system to deliver drugs directly to infection sites within the body. He was recently awarded a $1.3 million NIH grant to advance his research.
Original post by Addy Hatch, WSU News Big changes are coming to healthcare. That was the message behind three days of speakers and workshops at the TIPed Institute on the […]
By Charlie Powell, College of Veterinary Medicine PULLMAN, Wash.—Most, if not all, infections and diseases in animals and people are met with some level of the body’s own inflammatory response. […]
By Judith Van Dongen, WSU Spokane Office of Research Scientists at Washington State University are leading a new study that will take them one step closer to making treatment options […]
SPOKANE, Wash.—Panshak Dakup, a graduate student at Washington State University in Spokane, received a Pre-doctoral Fellowship from the American Heart Association (AHA). The fellowship comes with $53,688 over two years […]
Washington State University researchers have found a new way to fight sepsis, a systemic inflammatory response that can cause organ failure. In a research study published in the journal Advanced Materials, […]
Ruby Siegel is searching for a better way to treat rheumatoid arthritis. According to Siegel, this painful auto-immune disease affects one percent of the population worldwide and currently there is […]
Welcome back to the final segment of our three-part series on the Center of Excellence for Natural Product-Drug Interaction Research (NaPDI Center). Interactions between natural products and conventional drugs are […]